country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-14135

Copy Link Print Information

BMS 488043

(別名: BMS 043)

BMS 488043 (BMS 043) is an orally active and well-tolerated inhibitor of the attachment of human immunodeficiency virus type 1 (HIV-1) to CD4+ lymphocytes.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 452296-83-2
分子式: C₂₂H₂₂N₄O₅
分子量:422.43

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (271 KB)

BMS 488043 構造式

CAS 番号: 452296-83-2

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

BMS 488043 (BMS 043) is an orally active and well-tolerated inhibitor of the attachment of human immunodeficiency virus type 1 (HIV-1) to CD4+ lymphocytes^[1].

HIV アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
Cancer cell lines	CC₅₀	>=120 μM Compound: 4, BMS-488043	Cytotoxicity against human cervical cancer cells Cytotoxicity against human cervical cancer cells	[PMID: 19769332]
Cancer cell lines	CC₅₀	>=120 μM Compound: 4, BMS-488043	Cytotoxicity against human hepatic cancer cells Cytotoxicity against human hepatic cancer cells	[PMID: 19769332]
Cancer cell lines	CC₅₀	>=120 μM Compound: 4, BMS-488043	Cytotoxicity against human larynx cancer cells Cytotoxicity against human larynx cancer cells	[PMID: 19769332]
Cancer cell lines	CC₅₀	>=120 μM Compound: 4, BMS-488043	Cytotoxicity against human lung cancer cell Cytotoxicity against human lung cancer cell	[PMID: 19769332]
HEK293	CC₅₀	>=120 μM Compound: 4, BMS-488043	Cytotoxicity against HEK cells Cytotoxicity against HEK cells	[PMID: 19769332]
HeLa	CC₅₀	>300 μM Compound: 2, BMS-488043	Cytotoxicity against human HeLa cells expressing CD4 assessed as cell viability after 6 days by XTT assay Cytotoxicity against human HeLa cells expressing CD4 assessed as cell viability after 6 days by XTT assay	[PMID: 23200252]
HeLa	EC₅₀	0.75 nM Compound: 2, BMS-488043	Antiviral activity against HIV1 JRFL infected in human HeLa cells expressing CD4 and CCR5 assessed as inhibition of single-cycle viral replication by luciferase reporter gene assay Antiviral activity against HIV1 JRFL infected in human HeLa cells expressing CD4 and CCR5 assessed as inhibition of single-cycle viral replication by luciferase reporter gene assay	[PMID: 23200252]
HeLa	CC₅₀	248 μM Compound: 1, BMS-488043	Cytotoxicity against human HeLa cells Cytotoxicity against human HeLa cells	[PMID: 23360431]
MT2	CC₅₀	>300 μM Compound: 4, BMS-488043	Cytotoxicity against human MT2 cells after 3 days by XTT assay Cytotoxicity against human MT2 cells after 3 days by XTT assay	[PMID: 19769332]
MT2	EC₅₀	3.44 nM Compound: 1, BMS-488043	Antiviral activity against X4-tropic HIV1 LAI infected in MT2 cells Antiviral activity against X4-tropic HIV1 LAI infected in MT2 cells	[PMID: 23360431]
MT2	EC₅₀	5.58 nM Compound: 1, BMS-488043	Antiviral activity against X4-tropic HIV1 NL4-3 infected in MT2 cells Antiviral activity against X4-tropic HIV1 NL4-3 infected in MT2 cells	[PMID: 23360431]
MT2	EC₅₀	8.32 nM Compound: 1, BMS-488043	Antiviral activity against X4-tropic HIV1 MN infected in MT2 cells Antiviral activity against X4-tropic HIV1 MN infected in MT2 cells	[PMID: 23360431]
MT2	CC₅₀	>300 μM Compound: 2; BMS-488043	Cytotoxicity against human MT2 cells assessed as decrease in cell viability after 3 days by XTT assay Cytotoxicity against human MT2 cells assessed as decrease in cell viability after 3 days by XTT assay	[PMID: 29920093]
PBMC	CC₅₀	>=120 μM Compound: 4, BMS-488043	Cytotoxicity against human PBMC Cytotoxicity against human PBMC	[PMID: 19769332]
T-cell	CC₅₀	>=120 μM Compound: 4, BMS-488043	Cytotoxicity against human T cell Cytotoxicity against human T cell	[PMID: 19769332]
U-87MG ATCC	IC₅₀	26 nM Compound: 27, BMS-488043	Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay	[PMID: 18052117]
U-87MG ATCC	CC₅₀	>40000 nM Compound: 27, BMS-488043	Cytotoxicity against human U87 cells expressing CD4 and CXCR4 Cytotoxicity against human U87 cells expressing CD4 and CXCR4	[PMID: 18052117]
U-87MG ATCC	CC₅₀	>40000 nM Compound: 2, BMS-488043,BMS-043	Cytotoxicity against human U87 cells coexpressing CD4, CxCR4 receptors after 72 hrs Cytotoxicity against human U87 cells coexpressing CD4, CxCR4 receptors after 72 hrs	[PMID: 19534463]

化学情報

CAS 番号 452296-83-2
分子量 422.43
分子式 C₂₂H₂₂N₄O₅
SMILES

O=C(C1=CNC2=C1C(OC)=CN=C2OC)C(N3CCN(CC3)C(C4=CC=CC=C4)=O)=O
別名

BMS 043
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (271 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. George J Hanna, et al. Antiviral activity, pharmacokinetics, and safety of BMS-488043, a novel oral small-molecule HIV-1 attachment inhibitor, in HIV-1-infected subjects. Antimicrob Agents Chemother. 2011 Feb;55(2):722-8. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ

Amount: USD 0.00

生物活性
- 製品説明
化学情報
純度とドキュメンテーション
参考文献

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

BMS 488043

HIV アイソフォーム固有の製品をすべて表示

生物活性

化学情報

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

BMS 488043 関連分類

HY-14135 関連分類